Clinical Trial

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

Name: Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers — clinical trial record (NCT04747054)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PembroMetaRT

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Study to evaluate the efficacy of treatment by radiotherapy and pembrolizumab in newly diagnosed metastatic head \& neck cancers

Protocol Amendment History 1 change

notable Primary completion pushed: 2025-10-01 -> 2026-10-01 2026-08-01

Trial Details

NCT Number	NCT04747054
Lead Sponsor	UNICANCER Collaborators: GORTEC, National Cancer Institute, France
Conditions	Squamous Cell Carcinoma of Head and Neck
Enrollment	102 participants
Start Date	2021-12-01
Primary Completion	2026-10-01 (estimated)
Study Completion	2029-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-31